Evidence map›Paper›PMID 26152714›Full record

ArticleProteomics2015

Integration of RNA-seq and proteomics data with genomics for improved genome annotation in Apicomplexan parasites.

Natalie C Silmon de Monerri, Louis M Weiss

Open access · greenAbstract readComment
In one paragraph

Article in Proteomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Natalie C Silmon de MonerriDepartment of Pathology, Albert Einstein College of Medicine, New York, NY, USA.
Louis M WeissDepartment of Pathology, Albert Einstein College of Medicine, New York, NY, USA.
Albert Einstein College of Medicine · US

Funding

Toxoplasma gondii: cyst wallR01AI095094 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI WEISS, LOUIS M. · 2012 to 2016
$2.1M
Microsporidiosis: Rational TherapeuticsR56AI093220 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI WEISS, LOUIS M. · 2011 to 2011
$415k
Biotechnology and Biological Sciences Research Council BB/G010781/1Biotechnology and Biological Sciences Research Council BB/H024654/1NIAID NIH HHS R01 AI095094NIAID NIH HHS R01AI93220NIAID NIH HHS R56 AI093220
6 · The paper itself

Abstract

While high quality genomic sequence data is available for many pathogenic organisms, the corresponding gene annotations are often plagued with inaccuracies that can hinder research that utilizes such genomic data. Experimental validation of gene models is clearly crucial in improving such gene annotations; the field of proteogenomics is an emerging area of research wherein proteomic data is applied to testing and improving genetic models. Krishna et al. [Proteomics 2015, 15, 2618-2628] investigated whether incorporation of RNA-seq data into proteogenomics analyses can contribute significantly to validation studies of genome annotation, in two important parasitic organisms Toxoplasma gondii and Neospora caninum. They applied a systematic approach to combine new and previously published proteomics data from T. gondii and N. caninum with transcriptomics data, leading to substantially improved gene models for these organisms. This study illustrates the importance of incorporating experimental data from both proteomics and RNA-seq studies into routine genome annotation protocols.

Indexed as

GenomicsNeosporaProteomicsToxoplasmaApicomplexaNeosporaProteogenomicsProtozoaToxoplasma

Identifiers

PMID26152714
PMCPMC4552184
OpenAlexW1872959741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.